Transcriptional control of early B cell development

Annual Review of Immunology

Volumn 22, Issue , 2004, Pages 55-79

  Busslinger, Meinrad ^a  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

E2A; EBF; Ikaros; Pax5; PU.1

Indexed keywords

CELL RECEPTOR; HISTONE; IKAROS TRANSCRIPTION FACTOR; IMMUNOGLOBULIN HEAVY CHAIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 7 RECEPTOR ALPHA; LYMPHOID ENHANCER FACTOR 1; RECEPTOR PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR EBF; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PU 1; TRANSCRIPTION FACTOR SOX4; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3; WNT PROTEIN;

B LYMPHOCYTE; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN STRUCTURE; EPIGENETICS; GENE EXPRESSION; GENE REARRANGEMENT; GENE REPRESSION; HEMATOPOIETIC STEM CELL; HIGH MOBILITY GROUP BOX DOMAIN; HUMAN; LYMPHOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE SYSTEM; TRANSCRIPTION, GENETIC;

EID: 2542442633     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.22.012703.104807     Document Type: Review

References (151)

1. Kondo M, Weissman IL, Akashi K. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661-72
2. Akashi K, Traver D, Miyamoto T, Weissman IL. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193-97
3. + stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15:659-69
4. Christensen JL, Weissman IL. 2001. Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98:14541-46
5. Igarashi H, Gregory SC, Yokota T, Sakaguchi N, Kincade PW 2002. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17:117-30
6. Allman D, Sambandam A, Kim S, Miller JP, Pagan A, et al. 2003. Thymopoiesis independent of common lymphoid progenitors. Nat. Immunol. 4:168-74
7. Traver D, Akashi K, Manz M, Merad M, Miyamoto T, et al. 2000. Development of CD8α-positive dendritic cells from a common myeloid progenitor. Science 290:2152-54
8. Gounari F, Aifantis I, Martin C, Fehling HJ, Hoeflinger S, et al. 2002. Tracing lymphopoiesis with the aid of a pTα-controlled reporter gene. Nat. Immunol. 3:489-96
9. + lymphoid-restricted bone marrow cells with T precursor potential. Nat. Immunol. 4:866-73
10. Li Y-S, Wasserman R, Hayakawa K, Hardy RR. 1996. Identification of the earliest B lineage stage in mouse bone marrow. Immunity 5:527-35
11. Tudor KS, Payne KJ, Yamashita Y, Kincade PW. 2000. Functional assessment of precursors from murine bone marrow suggests a sequence of early B lineage differentiation events. Immunity 12:335-45
12. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Kayakawa K. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213-25
13. Li Y-S, Hayakawa K, Hardy RR. 1993. The regulated expression of B lineage-associated genes during B cell differentiation in bone marrow and fetal liver. J. Exp. Med. 178:951-60
14. Meffre E, Casellas R, Nussenzweig MC. 2000. Antibody regulation of B cell development. Nat. Immunol. 1:379-85
15. Domen J, Weissman IL. 2000. Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J. Exp. Med. 192:1707-18
16. W/W mutants reveal pivotal role for c-Kit in the maintenance of lymphopoiesis. Immunity 17:277-88
17. McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, et al. 2000. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95:3489-97
18. Sitnicka E, Bryder D, Theilgaard-Mönch K, Buza-Vidas N, Adolfsson J, Jacobsen SEW. 2002. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 17:463-72
19. Miller JP, Izon D, DeMuth W, Gerstein R, Bhandoola A, Allman D. 2002. The earliest step in B lineage differentiation from common lymphoid progenitors is critically dependent upon interleukin 7. J. Exp. Med. 196:705-11
20. -/- mice. J. Exp. Med. 194:1141-50
21. Vosshenrich CAJ, Cumano A, Müller W, Di Santo JP, Vieira P. 2003. Thymic stroma-derived lymphopoietin distinguishes fetal from adult B cell development. Nat. Immunol. 4:773-79
22. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR. 1995. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147-61
23. Schebesta M, Heavey B, Busslinger M. 2002. Transcriptional control of B cell development. Curr. Opin. Immunol. 14:216-23
24. Georgopoulos K. 2002. Haematopoietic cell-fate decisions, chromatin regulation and Ikaros. Nat. Rev. Immunol. 2:162-74
25. Morgan B, Sun L, Avitahl N, Andrikopoulos K, Ikeda T, et al. 1997. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16:2004-13
26. Kelley CM, Ikeda T, Koipally J, Avitahl N, Wu L, et al. 1998. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr. Biol. 8:508-15
27. Klug CA, Morrison SJ, Masek M, Hahm K, Smale ST, Weissman IL. 1998. Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes. Proc. Natl. Acad. Sci. USA 95:657-62
28. Sun L, Liu A, Georgopoulos K. 1996. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 15:5358-69
29. Georgopoulos K, Bigby M, Wang J-H, Molnar A, Wu P, et al. 1994. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79:143-56
30. Wang J-H, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, et al. 1996. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5:537-49
31. Wu L, Nichogiannopoulou A, Shortman K, Georgopoulos K. 1997. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 7:483-92
32. Nichogiannopoulou A, Trevisan M, Neben S, Friedrich C, Georgopoulos K. 1999. Defects in hematopoietic stem cell activity in Ikaros mutant mice. J. Exp. Med. 190:1201-13
33. Kirstetter P, Thomas M, Dierich A, Kastner P, Chan S. 2002. Ikaros is critical for B cell differentiation and function. Eur. J. Immunol. 32:720-30
34. Wang JH, Avitahl N, Cariappa A, Friedrich C, Ikeda T, et al. 1998. Aiolos regulates B cell activation and maturation to effector state. Immunity 9:543-53
35. Lopez RA, Schoetz S, DeAngelis K, O'Neill D, Bank A. 2002. Multiple hematopoietic defects and delayed globin switching in Ikaros null mice. Proc. Natl. Acad. Sci. USA 99:602-7
36. Dumortier A, Kirstetter P, Kastner P, Chan S. 2003. Ikaros regulates neutrophil differentiation. Blood 101:2219-26
37. Koipally J, Renold A, Kim J, Georgopoulos K. 1999. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J. 18:3090-100
38. Kim J, Sif S, Jones B, Jackson A, Koipally J, et al. 1999. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10:345-55
39. Koipally J, Georgopoulos K. 2000. Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity. J. Biol. Chem. 275:19594-602
40. Harker N, Naito T, Cortes M, Hostert A, Hirschberg S, et al. 2002. The CD8α gene locus is regulated by the Ikaros family of proteins. Mol. Cell 10:1403-15
41. Brown KE, Guest SS, Smale ST, Hahm K, Merkenschlager M, Fisher AG. 1997. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91:845-54
42. Cobb BS, Morales-Alcelay S, Kleiger G, Brown KE, Fisher AG, Smale ST. 2000. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev. 14:2146-60
43. Scott EW, Simon MC, Anastasi J, Singh H. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573-77
44. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, et al. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:5647-6658
45. Hromas R, Orazi A, Neiman R, Maki R, Van Beveran C, et al. 1993. Hematopoietic lineage- and stage-restricted expression of the ETS oncogen family member PU.1. Blood 82:2998-3004
46. Anderson MK, Hernandez-Hoyos G, Diamond RA, Rothenberg EV. 1999. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development 126:3131-48
47. Scott EW, Fisher RC, Olson MC, Kehrli EW, Simon MC, Singh H. 1997. PU.1 functions in a cell-autonomous manner to control the differentiation of multi-potential lymphoid-myeloid progenitors. Immunity 6:437-47
48. Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, et al. 1997. Osteopetrosis in mice lacking haematopoeitic transcription factor PU.1. Nature 386:81-84
49. Walsh JC, DeKoter RP, Lee HJ, Smith ED, Lancki DW, et al. 2002. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity 17:665-76
50. DeKoter RP, Walsh JC, Singh H. 1998. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J. 17:4456-68
51. Colucci F, Samson SI, DeKoter RP, Lantz O, Singh H, Di Santo JP. 2001. Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. Blood 97:2625-32
52. Spain LM, Guerriero A, Kunjibettu S, Scott EW 1999. T cell development in PU.1-deficient mice. J. Immunol 163:2681-87
53. DeKoter RP, Lee H-J, Singh H. 2002. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16:297-309
54. DeKoter RP, Singh H. 2000. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288:1439-41
55. Murre C, McCaw PS, Baltimore D. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56:777-83
56. Shen CP, Kadesch T. 1995. B-cell-specific DNA binding by an E47 homodimer. Mol. Cell. Biol. 15:4518-24
57. Sloan SR, Shen C-P, McCarrick-Walmsley R, Kadesch T. 1996. Phosphorylation of E47 as a potential determinant of B-cell-specific activity. Mol. Cell. Biol. 16:6900-8
58. Zhuang Y, Barndt RJ, Pan L, Kelley R, Dai M. 1998. Functional replacement of the mouse E2A gene with a human HEB cDNA. Mol. Cell. Biol. 18:3340-49
59. Bain G, Maandag ECR, Izon DJ, Amsen D, Kruisbeek AM, et al. 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885-92
60. Zhuang Y, Soriano P, Weintraub H. 1994. The helix-loop-helix gene E2A is required for B cell formation. Cell 79:875-84
61. Bain G, Maandag ECR, te Riele HPJ, Feeney AJ, Sheehy A, et al. 1997. Both E12 and E47 allow commitment to the B cell lineage. Immunity 6:145-54
62. Zhuang Y, Cheng P, Weintraub H. 1996. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2 and HEB. Mol. Cell. Biol. 16:2898-905
63. Hagman J, Belanger C, Travis A, Turck CW, Grosschedl R. 1993. Cloning and functional characterization of early B-cell factor, a regulator of lymphocyte-specific gene expression. Genes Dev. 7:760-73
64. Hagman J, Gutch MJ, Lin H, Grosschedl R. 1995. EBF contains a novel zinc coordination motif and multiple dimerization and transcriptional activation domains. EMBO J. 14:2907-16
65. Lin H, Grosschedl R. 1995. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376:263-67
66. O'Riordan M, Grosschedl R. 1999. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11:21-31
67. Schlissel M, Voronova A, Baltimore D. 1991. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T cell line. Genes Dev. 5:1367-76
68. Choi JK, Shen C-P, Radomska HS, Eckhardt LA, Kadesch T. 1996. E47 activates the Ig-heavy chain and TdT loci in non-B cells. EMBO J. 15:5014-21
69. Kee BL, Murre C. 1998. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J. Exp. Med. 188:699-713
70. Sigvardsson M, O'Riordan M, Grosschedl R. 1997. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 7:25-36
71. Sigvardsson M. 2000. Overlapping expression of early B-cell factor and basic helix-loop-helix proteins as a mechanism to dictate B-lineage-specific activity of the A.5 promoter. Mol. Cell. Biol. 20:3640-54
72. Gisler R, Sigvardsson M. 2002. The human V-preB promoter is a target for coordinated activation by early B cell factor and E47. J. Immunol. 168:5130-38
73. Sigvardsson M, Clark DR, Fitzsimmons D, Doyle M, Akerblad P, et al. 2002. Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B-cell-specific mb-1 promoter. Mol. Cell. Biol. 22:8539-51
74. Akerblad P, Rosberg M, Leanderson T, Sigvardsson M. 1999. The B29 (immunoglobulin β-chain) gene is a genetic target for early B-cell factor. Mol. Cell. Biol. 19:392-401
75. Greenbaum S, Zhuang Y. 2002. Identification of E2A target genes in B lymphocyte development by using a gene tagging-based chromatin immunoprecipitation system. Proc. Natl. Acad. Sci. USA 99:15030-35
76. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. 1990. The protein Id: a negative regulator of helix-loop-helix DNA-binding proteins. Cell 61:49-59
77. Sun X-H. 1994. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 79:893-900
78. Kee BL, Rivera RR, Murre C. 2001. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat. Immunol. 2:242-41
79. Kee BL, Bain G, Murre C. 2002. IL-7Rα and E47: independent pathways required for development of multipotent lymphoid progenitors. EMBO J. 21:103-13
80. Romanow WJ, Langerak AW, Goebel P, Wolvers-Tettero ILM, van Dongen JJM, et al. 2000. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5:343-53
81. Goebel P, Janney N, Valenzuela JR, Romanow WJ, Murre C, Feeney AJ. 2001. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J. Exp. Med. 194:645-56
82. Serwe M, Sablitzky F. 1993. V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer. EMBO J. 12:2321-27
83. H locus. EMBO J. 12:4635-45
84. Massari ME, Grant PA, Pray-Grant MG, Berger SL, Workman JL, Murre C. 1999. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol. Cell. 4:63-73
85. Smith EM, Gisler R, Sigvardsson M. 2002. Cloning and characterization of a promoter flanking the early B cell factor (EBF) gene indicates roles for E-proteins and autoregulation in the control of EBF expression. J. Immunol. 169:261-70
86. Adams B, Dörfler P, Aguzzi A, Kozmik Z, Urbánek P, et al. 1992. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 6:1589-607
87. Urbánek P, Wang Z-Q, Fetka I, Wagner EF, Busslinger M. 1994. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79:901-12
88. Nutt SL, Urbánek P, Rolink A, Busslinger M. 1997. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 11:476-91
89. Nutt SL, Heavey B, Rolink AG, Busslinger M. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401:556-62
90. Rolink AG, Nutt SL, Melchers F, Busslinger M. 1999. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 401:603-6
91. Schaniel C, Bruno L, Melchers F, Rolink AG. 2002. Multiple hematopoietic cell lineages develop in vivo from transplanted Pax5-deficient pre-B I-cell clones. Blood 99:472-78
92. Schaniel C, Gottar M, Roosnek E, Melchers F, Rolink AG. 2002. Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clones. Blood 99:2760-66
93. Heavey B, Charalambous C, Cobaleda C, Busslinger M. 2003. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPα and GATA factors. EMBO J. 22:3887-97
94. Horcher M, Souabni A, Busslinger M. 2001. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 14:779-90
95. Mikkola I, Heavey B, Horcher M, Busslinger M. 2002. Reversion of B cell commitment upon loss of Pax5 expression. Science 297:110-13
96. Hu M, Krause D, Greaves M, Sharkis S, Dexter M, et al. 1997. Multilineage gene expression precedes commitment in the hematopoietic system. Genes Dev. 11:774-85
97. Nutt SL, Morrison AM, Dörfler P, Rolink A, Busslinger M. 1998. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 17:2319-33
98. Souabni A, Cobaleda C, Schebesta M, Busslinger M. 2002. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity 17:781-93
99. Fitzsimmons D, Hodsdon W, Wheat W, Maira S-M, Wasylyk B, Hagman J. 1996. Pax-5 (BSAP) recruits Ets protooncogene family proteins to form functional ternary complexes on a B cell-specific promoter. Genes Dev. 10:2198-211
100. Kozmik Z, Wang S, Dörfler P, Adams B, Busslinger M. 1992. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 12:2662-72
101. Schebesta M, Pfeffer PL, Busslinger M. 2002. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity 17:473-85
102. Hayashi K, Yamamoto M, Nojima T, Goitsuka R, Kitamura D. 2003. Distinct signaling requirements for Dμ selection, IgH allelic exclusion, pre-B cell transition, and tumor suppression of B cell progenitors. Immunity 18:825-36
103. Hesslein DGT, Pflugh DL, Chowdhury D, Bothwell ALM, Sen R, Schatz DG. 2003. Pax5 is required for recombination of transcribed, acetylated, 5′ IgH V gene segments. Genes Dev. 17:37-42
104. Eberhard D, Jiménez G, Heavey B, Busslinger M. 2000. Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. EMBO J. 19:2292-303
105. Linderson Y, Eberhard D, Malin S, Johansson A, Busslinger M, Pettersson S. 2003. Co-recruitment of the Grg4 represser by PU.1 is critical for Pax5-mediated repression of B-cell-specific genes. EMBO Rep. In press
106. Garvie CW, Hagman J, Wolberger C. 2001. Structural studies of Ets-1/Pax5 complex formation on DNA. Mol. Cell 8:1267-76
107. Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, et al. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397:702-6
108. Ikawa T, Fujimoto S, Kawamoto H, Katsura Y, Yokota Y. 2001. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc. Natl. Acad. Sci. USA 98:5164-69
109. Hacker C, Kirsch RD, Ju X-S, Hieronymus T, Gust TC, et al. 2003. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4:380-86
110. + dendritic cell subset in Id2-deficient mice. J. Allergy Clin. Immunol. 111:136-42
111. Jaleco AC, Stegmann APA, Heemskerk MHM, Couwenberg F, Bakker AQ, et al. 1999. Genetic modification of human B-cell development: B-cell development is inhibited by the dominant negative helix loop helix factor Id3. Blood 94:2631-46
112. + stem cells into predendritic cell (pre-DC)2 but not into pre-DC1: Evidence for a lymphoid origin of pre-DC2. J. Exp. Med. 192:1775-84
113. Izon DJ, Punt JA, Pear WS. 2002. Deciphering the role of Notch signaling in lymphopoiesis. Curr. Opin. Immunol. 14:192-99
114. Pui JC, Allman D, Xu L, DeRocco S, Karnell FG, et al. 1999. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11:299-308
115. Jaleco AC, Neves H, Hooijberg E, Gameiro P, Clode N, et al. 2001. Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J. Exp. Med. 194:991-1001
116. Schmitt TM, Zúñiga-Pflücker JC. 2002. Induction of T cell development from hematopoietic progenitor cells by Delta-like-1 in vitro. Immunity 17:749-56
117. Radtke F, Wilson A, Stark G, Bauer M, van Meerwijk J, et al. 1999. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10:547-58
118. Wilson A, MacDonald HR, Radtke F. 2001. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J. Exp. Med. 194:1003-12
119. Ordentlich P, Lin A, Shen C-P, Blaumueller C, Matsuno K, et al. 1998. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol. Cell. Biol. 18:2230-39
120. Cotta CV, Zhang Z, Kim H-G, Klug CA. 2003. Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development. Blood 101:4342-46
121. van Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519-26
122. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180:1955-60
123. Reya T, O'Riordan M, Okamura R, Devaney E, Willert K, et al. 2000. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13:15-24
124. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, et al. 2003. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423:409-14
125. van de Wetering M, Oosterwegel M, van Norren K, Clevers H. 1993. Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J. 12:3847-54
126. Schilham MW, Oosterwegel MA, Moerer P, Ya J, de Boer PAJ, et al. 1996. Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature 380:711-14
127. Geijsen N, Uings U, Pals C, Armstrong J, McKinnon M, et al. 2001. Cytokine-specific transcriptional regulation through an IL-5Rα interacting protein. Science 293:1136-38
128. Yoshida T, Ikuta K, Sugaya H, Maki K, Takagi M, et al. 1996. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5Rα-deficient mice. Immunity 4:483-94
129. Grootjans JJ, Zimmermann P, Reekmans G, Smets A, Degeest G, et al. 1997. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc. Natl. Acad. Sci. USA 94:13683-88
130. Lin D, Gish GD, Songyang Z, Pawson T. 1999. The carboxyl terminus of B class ephrins constitutes a PDZ domain binding motif. J. Biol. Chem. 274:3726-33
131. Lu R, Medina KL, Lancki DW, Singh H. 2003. IRF-4/8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 17:1703-8
132. Wang YH, Stephan RP, Scheffold A, Kunkel D, Karasuyama H, et al. 2002. Differential surrogate light chain expression governs B-cell differentiation. Blood 99:2459-67
133. Jenuwein T, Allis CD. 2001. Translating the histone code. Science 293:1074-1080
134. Turner BM. 2002. Cellular memory and the histone code. Cell 111:285-91
135. o cells. Science 296:1132-36
136. Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ III. 2002. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev. 16:919-32
137. Krangel MS. 2003. Gene segment selection in V(D)J recombination: accessibility and beyond. Nat. Immunol. 4:624-30
138. McMurry MT, Krangel MS. 2000. A role for histone acetylation in the developmental regulation of V(D)J recombination. Science 287:495-98
139. Chowdhury D, Sen R. 2001. Stepwise activation of the immunoglobulin μ heavy chain gene locus. EMBO J. 20:6394-403
140. H gene segments to V-DJ recombination during B-cell ontogeny and development. Mol. Cell. Biol. 23:2438-50
141. Chowdhury D, Sen R. 2003. Transient IL-7/IL-7R signaling provides a mechanism for feedback inhibition of immunoglobulin heavy chain gene rearrangements. Immunity 18:229-41
142. Su IH, Basavaraj A, Krutchinsky AN, Hobert O, Ullrich A, et al. 2003. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat. Immunol. 4:124-31
143. Smale ST. 2003. The establishment and maintenance of lymphocyte identity through gene silencing. Nat. Immunol. 4:607-15
144. Kosak ST, Skok JA, Medina KL, Riblet R, Le Beau MM, et al. 2002. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296:158-62
145. Brown KE, Baxter J, Graf D, Merkenschlager M, Fisher AG. 1999. Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division. Mol. Cell 3:207-17
146. + thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev. 15:1817-32
147. Avitahl N, Winandy S, Friedrich C, Jones B, Ge Y, Georgopoulos K. 1999. Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity 10:333-43
148. Koipally J, Heller EJ, Seavitt JR, Georgopoulos K. 2002. Unconventional potentiation of gene expression by Ikaros. J. Biol. Chem. 277:13007-15
149. O'Neill DW, Schoetz SS, Lopez RA, Castle M, Rabinowitz L, et al. 2000. An Ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. Mol Cell Biol. 20:7572-82
150. Sif S, Saurin AJ, Imbalzano AN, Kingston RE. 2001. Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. Genes Dev. 15:603-18
151. Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, et al. 2003. Bel11a is essential for normal lymphoid development. Nat. Immunol. 4:525-32